---
figid: PMC9012636__ECAM2022-5581864.014
pmcid: PMC9012636
image_filename: ECAM2022-5581864.014.jpg
figure_link: /pmc/articles/PMC9012636/figure/fig14/
number: Figure 14
figure_title: ''
caption: Pathway map of ÜS against ICVD. The key targets of ÜS in the treatment of
  ICVD are shown as rose in the PI3K/AKT signaling pathway.
article_title: 'Study on the Mechanism of Üstikuddus Sherbiti in Ischemic Cerebrovascular
  Diseases: Based on Network Pharmacology.'
citation: Aman Gul, et al. Evid Based Complement Alternat Med. 2022;2022:5581864.
year: '2022'

doi: 10.1155/2022/5581864
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
